In an announcement made on Wednesday, September 1, 2010, Allergan Inc. will pay $600 million in fines to settle a federal investigation into marketing practices for the company's top-...
A study published Tuesday in the Journal of the American Medical Association found that women with mutations in common breast cancer genes who opted to surgically remove their...
In an announcement made last week by the U.S. Drug Enforcement Administration (DEA), a first-ever nationwide public health campaign called the "Take-Back" initiative will be unveiled...
Findings from a phase I clinical trial showed that a new experimental drug may extend progression-free survival in certain patients suffering from advanced melanoma, the most severe form...